Details



REVIEW ON ENVIRONMENTAL EFFECTS OF HEALTH WASTE IN HOSPITALS

Dr. Nagham Mahmood Aljamali, Alaa Hamza Jaber Al-jelehawy, Dr. Afaq Jaber Kadhium, Dr. Muhsin Mohammed Al Najim, Anaam Jawad Alabbasy

50-64

Vol. 10, Jul-Dec, 2019

Date of Submission: 2019-11-08 Date of Acceptance: 0019-11-12 Date of Publication: 2019-11-17

Abstract

This review involved effect of health waste in hospitals on environment, Non-hazardous waste is generally 85% of the total amount of waste from healthcare activities. The remaining 15% are hazardous materials that can transmit infection or be toxic or radioactive. An estimated 16 billion syringes are given each year worldwide, but not all syringes and needles are disposed of properly after their use. Healthcare waste is sometimes burned, and this incineration may produce emissions in the form of dioxins, furans, and other toxic air pollutants. There is no doubt that the problem of environmental pollution is closely related to the means of development. Environmental pollution is one of its biggest complications despite the maximum benefit that is achieved for everyone from technological development, and what is meant by environmental pollution in general is that change that may occur in the natural, chemical and biological characteristics of the environment in which a person lives, which causes very harmful effects on human health.

References

  1. Rosenthal VD. (2012). International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009. In: Am J Infect Control; 40(5):396-407. https://doi .org/10.101 6/j.ajic.2011.05.020
  2. Klevens, R. Monina; Edwards, Jonathan R.; Richards, Chesley L.; Horan, Teresa C.; Gaynes, Robert P; Pollock, Daniel A.; Cardo, Denise M. (2007). 'Estimating Healthcare-associated Infections and Deaths in U.S. Hospitals, 2002'. Public Health Reports. 122 (2): 160–166. doi:10.1177/003335 490712200205 .
  3. Nagham Mahmood Aljamali, Aseel Mahmood Jawad , Imad Kareem Alwan Alsabri., 'Public Health in Hospitals ', 1 First Edition, 2020, Eliva Press ,ISBN: 9798636352129 .
  4. Aseel Mahmood Jawad, Nagham Mahmood Aljamali, Aseel M J .(2020). Innovation, Preparation of Cephalexin Drug Derivatives and Studying of (Toxicity & Resistance of Infection)' .,International Journal of Psychosocial Rehabilitation, 24, 4 , 3754-3767 ., DOI: 10.37200/IJPR/V24I4/PR201489 .
  5. Burke A Cunha (2018). John L Brusch (ed.). 'Hospital-Acquired Pneumonia (Nosocomial Pneumonia) and Ventilator-Associated Pneumonia: Overview, Pathophysiology, Etiology' . Webscape
  6. Su, Lin-Hui; Ou, Jonathan T.; Leu, Hsieh-Shong; Chiang, Ping-Cherng; Chiu, Yueh-Pi; Chia, Ju-Hsin; Kuo, An-Jing; Chiu, Cheng-Hsun; Chu, Chishih (2003). 'Extended Epidemic of Nosocomial Urinary Tract Infections Caused by Serratia marcescens'. Journal of Clinical Microbiology. 41 (10): 4726–4732. doi:10 .1128/JCM.41.10.4726-4732.2003.
  7. Nagham Mahmood Aljamali., Imad Kareem Alwan A., Hasaneen Kudhair Abdullabass., Aseel Mahmood Jawad., Intisar O Alfatlawi ., Ahmed Adnan Abdul H ., Manar Ghyath Abd Almutalib A ,'Review in SARS-Corona Virus (Types, Infection, Diagnosis, Chemical Antiseptics for this Virus)', Journal of Science and Technology, Vol. 05, Issue 3 , May- June 2020 , pp.:111-224.
  8. Aseel Mahmood Jawad, Nagham Mahmood Aljamali, Saher Mahmood Jwad., Aseel M J. Development and Preparation of ciprofloxacin Drug Derivatives for Treatment of Microbial Contamination in Hospitals and Environment, Indian Journal of Forensic Medicine & Toxicology ,2020,14, 2, p:1115-1122.
  9. Imad Kareem Alwan Alsabri, Hasaneen Kudhair Abdullabass , Nagham Mahmood Aljamali., Invention of (Gluta.Sulfazane-Cefixime) Compounds as Inhibitors of Cancerous Tumors., J. Cardiovascular Disease Res. 2020; 11 (2): 44-55., doi:10.31838/jcdr.2020.11.02.09
  10. Aseel Mahmood Jawad, Nagham Mahmood Aljamali, Saher Mahmood Jwad ,Aseel M J, Saher M J, Development and Preparation of ciprofloxacin Drug Derivatives for Treatment of Microbial Contamination in Hospitals and Environment, Indian Journal of Forensic Medicine & Toxicology , 2020,14, 2, p:1115-1122.
  11. Nagham Mahmood Aljamali ,Muhsin Mohammed Al Najim., Review in Hospital-Acquired Infection ., International Journal of Advances in Engineering Research ., 2020, Vol. No. 20, Issue No. III, pp: 7-20.
  12. Jain SK, Persaud D, Perl TM. (July 2005). 'Nosocomial malaria and saline flush'. Emerging Infect. Dis. 11 (7): 1097–9. doi:10.3201/eid1107.050092. PMC 3371795. PMID 16022788.
  13. Leung M, Chan AH (March 2006). 'Control and management of hospital indoor air quality'. Med. Sci. Monit. 12 (3): SR17–23. PMID 16501436.
  14. Chan PC, Huang LM, Lin HC. (April 2007). 'Control of an outbreak of pandrug-resistant Acineto bacter baumannii colonization and infection in a neonatal intensive care unit'. Infect Control Hosp Epidemiol. 28 (4): 423–9. doi:10.1086/513120. PMID 17385148.
  15. Traub-Dargatz JL, Weese JS, Rousseau JD, Dunowska M, Morley PS, Dargatz DA (2006). 'Pilot study to evaluate 3 hygiene protocols on the reduction of bacterial load on the hands of veterinary staff performing routine equine physical examinations'. Can. Vet. J. 47 (7): 671–6. PMC 1482439 . PMID 16898109.
  16. Nagham Mahmood Aljamali , Hasaneen Kudhair Abdullabass, Aseel Mahmood Jawad, Intisar Obaid Alfatlawi, Saher Mahmood Jawd. Review on Types of Automatic Sterilization Systems in Hospitals. International Journal of Industrial Biotechnology and Biomaterials. 2020; 6(1): 15–21p.
  17. Kolár, M.; Urbánek, K.; Látal, T. (May 2001). 'Antibiotic selective pressure and development of bacterial resistance'. International Journal of Antimicrobial Agents. 17 (5): 357–363. doi:10. 1016/S0924-8579(01)00317-X. ISSN 0924-8579. PMID 11337221.
  18. 'The Different Methods of Sterilizing Medical Equipment'. Gibraltar Laboratories. 2013-05-31. Retrieved 2018-12-06.
  19. World Alliance for patient safety. WHO Guidelines on Hand Hygiene in Health Care. http://www. who.int/rpc/guidelines/9789241597906/en/. 2009
  20. Hugonnet S, Perneger TV, Pittet D. Alcohol based hand rub improves compliance with hand hygiene in intensive care units. Arch Intern med 2002; 162: 1037-1043.
  21. Nagham Mahmood Aljamali, Hasaneen Kudhair Abdullabass, Imad Kareem Alwan Alsabri , Nemah Sahib Mohammed Husien , Ahmed Adnan Abdul Hussein, Wisam Hasan Ali Alfatoosi. Review on Reasons for The Spread of Corona Virus , International Journal of Cell Biology and Cellular Processes. 2020; 6(1): 30-39p
  22. Haverstick, Stacy; Goodrich, Cara; Freeman, Regi; James, Shandra; Kullar, Rajkiran; Ahrens, Melissa ( 2017). 'Patients' Hand Washing and Reducing Hospital-Acquired Infection'. Critical Care Nurse. 37 (3): e1–e8. doi:10.4037/ccn2017694. PMID 28572111.
  23. Arrowsmith, VA; Taylor, R (Aug 4, 2014). 'Removal of nail polish and finger rings to prevent surgical infection'. The Cochrane Database of Systematic Reviews (8): CD003325. doi:10. 1002/14651858 .CD003325.pub3. PMID 25089848.
  24. Osterweil, Neil (2016). 'Bacteria Can Persist on Gloves, Transfer to Surfaces'. Medscape.
  25. Otter JA, French GL ( 2009). 'Survival of nosocomial bacteria and spores on surfaces and inactivation by hydrogen peroxide vapor'. J. Clin. Microbiol. 47(1): 205–7. doi:10.1128/JCM.02004-08. PM C 2620 839. PMID 18971364.
  26. Aseel Mahmood Jawad, Nagham Mahmood Aljamali, Aseel M J .,'Innovation, Preparation of Cephalexin Drug Derivatives and Studying of (Toxicity & Resistance of Infection)'., International Journal of Psychosocial Rehabilitation, Vol. 24, Issue 04, 2020 , 3754-3767 .
  27. Wilks, S.A., Michels, H., Keevil, C.W., 2005, The Survival of Escherichia Coli O157 on a Range of Metal Surfaces, International Journal of Food Microbiology, Vol. 105, pp. 445–454. and Michels, H.T. (2006), Anti-Microbial Characteristics of Copper, ASTM Standardization News, October, pp. 28-31
  28. U.S. Department of Defense-funded clinical trials, as presented at the Inter science Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, D.C., October 28, 2008
  29. Weber, DJ; Rutala, WA ( 2013). 'Self-disinfecting surfaces: review of current methodologies and future prospects'. American Journal of Infection Control. 41 (5): S31-5. doi:10.1016/ j.ajic. 2012.12.005. PMID 23622745.
  30. 'Portable Ultraviolet Light Surface-Disinfecting Devices for Prevention of Hospital-Acquired Infections: A Health Technology Assessment'. Ontario Health Technology Assessment Series. 18 (1): 1–73. 2018 . PMC 5824029. PMID 29487629.
  31. Weber, DJ; Kanamori, H; Rutala, WA (2016). ''No touch' technologies for environmental decontamination: focus on ultraviolet devices and hydrogen peroxide systems'. Current Opinion in Infectious Diseases . 29 (4): 424–31. doi:10.1097/QCO.0000000000000284.
  32. Nagham Mahmood Aljamali. 2016. ' Synthesis and Biological Study of Hetero (Atoms and Cycles) Compounds', Der PharmaChemica, 8,6, 40-48.
  33. Klevens RM, Edwards JR, Richards CL. (2007). 'Estimating health care-associated infections and deaths in U.S. hospitals, 2002'. Public Health Rep. 122(2): 160–6. doi:10.1177/003 33549 0712200205. PMC 1820440. PMID 17357358.
  34. Nagham Mahmood Aljamali, Aseel Mahmood Jawad, Intisar Obaid Alfatlawi, Saher Mahmood Jawd. Review on Hospital Bacteria (Causes, Infections, Prevention). International Journal of Cell Biology and Cellular Processes. 2020; 6(1): 1–8p
  35. Dai, T; Vrahas, MS; Murray, CK; Hamblin, MR (February 2012). 'Ultraviolet C irradiation: an alternative antimicrobial approach to localized infections?'. Expert Review of Anti-infective Therapy. 10 (2): 185–95. doi:10.1586/eri.11.166. PMC 3292282. PMID 22339192.
  36. Federaal Kenniscentrum voor de Gezondheidszorg (2009) Nosocomiale Infecties in België, deel II: Impact op Mortaliteit en Kosten. KCE-rapport 102A.
  37. Institut de veille sanitaire Enquête nationale de prévalence des infections nosocomiales, France, juin 2006, Volume 1 – Méthodes, résultats, perspectives, mars 2009, ii + 81 pp. Volume 2 – Annexes, mars 2009, ii + 91 pp. Synthèse des résultats, Mars 2009, 11 pp.
  38. Miad Mohmed ,Nagham Mahmood Aljamali ,Sabreen Ali Abdalrahman., Wassan Ala Shubber ., 'Formation of Oxadiazole Derivatives Ligands from Condensation and Imination Reaction with References To Spectral Investigation, Thermal and Microbial Assay'., Biochem. Cell. Arch., 2018 ,18, 1, pp. 847-853.
  39. Meaad M ,Nagham Mahmood Aljamali ,Nadheema A A .,'Preparation,Spectral Investigation, Thermal Analysis, Biochemical Studying of New (Oxadiazole -Five Membered Ring)-Ligands'., Journal of Global Pharmacy Technology,2018;10,1,20-29.
  40. Institut de veille sanitaire Enquête nationale de prévalence des infections nosocomiales, France, juin 2006, Vol. 1, Tableau 31, p. 24.
  41. Réseau REA-Raisin « Surveillance des infections nosocomiales en réanimation adulte. France, résultats 2007 », Institut de veille sanitaire, Sept. 2009, ii + 60 pp.
  42. Vasselle, Alain « Rapport sur la politique de lutte contre les infections nosocomiales », Office parlementaire d'évaluation des politiques de santé, juin 2006, 290 pp. (III.5. Quelle est l’estimation de la mortalité attribuable aux IN ?).
  43. Lyytikainen O, Kanerva M, Agthe N, Mottonen T and the Finish Prevalence Survey Study Group. National Prevalence Survey on Nosocomial Infections in Finnish Acute Care Hospitals, 2005. 10th Epiet Scientific Seminar. Mahon, Menorca, Spain, 13–15 October 2005 [Poster].
  44. Mestaf M, Nawfel Muhammed Baqer Muhsin., NeuroQuantology, 2019.,17,11, 11-16 .,10.14704/nq.2019. 17.11.NQ19108.
  45. Nagham Mahmood Aljamali.,Synthesis of Antifungal Chemical Compounds from Fluconazole with (Pharma-Chemical) Studying, Research journal of Pharmaceutical, biological and chemical sciences, 2017, 8 (3), 564 -573.
  46. Liziolia A, Privitera G, Alliata E, Antonietta Banfi EM, Boselli L, Panceri ML, Perna MC, Porretta AD, Santini MG, Carreri V. Prevalence of nosocomial infections in Italy: result from the Lombardy survey in 2000. J Hosp Infect 2003;54: 141-8.
  47. Boev C, Kiss E. Hospital-Acquired Infections: Current Trends and Prevention. Crit Care Nurs Clin North Am. 2017 Mar;29(1):51-65.
  48. Habboush Y, Guzman N. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Apr 27, 2020. Infection Control.
  49. Nagham Mahmood Aljamali., Aseel Mahmood Jawd., Anaam Jawad Alabbasy, Layla Ali M S. 2019.A Literature Review on Types of Contamination (Biological, Chemical, Medical). International Journal of International Journal of Green Chemistry.; 5 (1) 7–14p.
  50. Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O'Grady NP, Bartlett JG, Carratalà J, El Solh AA, Ewig S, Fey PD, File TM, Restrepo MI, Roberts JA, Waterer GW, Cruse P, Knight SL, Brozek JL. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia:. Clin. Infect. Dis. 2016 Sep 01;63(5):e61-e111.
  51. Cillóniz C, Dominedò C, Torres A. An overview of guidelines for the management of hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria. Curr. Opin. Infect. Dis. 2019 Dec;32(6):656-662. [PubMed]
  52. Sydnor ER, Perl TM. Hospital epidemiology and infection control in acute-care settings. Clin. Microbiol. Rev. 2011 Jan;24(1):141-73. [PMC free article]
  53. Metersky ML, Kalil AC. New guidelines for nosocomial pneumonia. Curr Opin Pulm Med. 2017 May;23(3):211-217.
  54. Stiller A, Schröder C, Gropmann A, Schwab F, Behnke M, Geffers C, Sunder W, Holzhausen J, Gastmeier P. ICU ward design and nosocomial infection rates: a cross-sectional study in Germany. J. Hosp. Infect. 2017 Jan;95(1):71-75.
  55. Novosad SA, Fike L, Dudeck MA, Allen-Bridson K, Edwards JR, Edens C, Sinkowitz-Cochran R, Powell K, Kuhar D. Pathogens causing central-line-associated bloodstream infections in acute-care hospitals-United States, 2011-2017. Infect Control Hosp Epidemiol. 2020 Mar;41(3):313-319.
  56. Flores-Mireles A, Hreha TN, Hunstad DA. Pathophysiology, Treatment, and Prevention of Catheter-Associated Urinary Tract Infection. Top Spinal Cord Inj Rehabil. 2019 Summer;25(3):228-240.
  57. Young PY, Khadaroo RG. Surgical site infections. Surg. Clin. North Am. 2014 Dec;94(6):1245-64.
  58. Babcock HM, Zack JE, Garrison T, Trovillion E, Kollef MH, Fraser VJ. Ventilator-associated pneumonia in a multi-hospital system: differences in microbiology by location. Infect Control Hosp Epidemiol. 2003 Nov;24(11):853-8.
  59. Eze P, Balsells E, Kyaw MH, Nair H. Risk factors for Clostridium difficile infections - an overview of the evidence base and challenges in data synthesis. J Glob Health. 2017 Jun;7(1):010417.
  60. Bell T, O'Grady NP. Prevention of Central Line-Associated Bloodstream Infections. Infect. Dis. Clin. North Am. 2017 Sep;31(3):551-559.
  61. Patel AR, Patel AR, Singh S, Singh S, Khawaja I. Central Line Catheters and Associated Complications: A Review. Cureus. 2019 May 22;11(5):e4717.
  62. Serra-Burriel M, Keys M, Campillo-Artero C, Agodi A, Barchitta M, Gikas A, Palos C, López-Casasnovas G. Impact of multi-drug resistant bacteria on economic and clinical outcomes of healthcare-associated infections in adults: Systematic review and meta-analysis. PLoS ONE. 2020;15(1):e0227139.
  63. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012 Mar;18(3):268-81
  64. Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O'Grady NP, Bartlett JG, Carratalà J, El Solh AA, Ewig S, Fey PD, File TM, Restrepo MI, Roberts JA, Waterer GW, Cruse P, Knight SL, Brozek JL. Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin. Infect. Dis. 2016 Sep 01;63(5):575-82
  65. Miller SE, Maragakis LL. Central line-associated bloodstream infection prevention. Curr. Opin. Infect. Dis. 2012 Aug;25(4):412-22.
  66. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin. Infect. Dis. 2009 Jul 01;49(1):1-45.
  67. Al Momani LA, Abughanimeh O, Boonpheng B, Gabriel JG, Young M. Fidaxomicin vs Vancomycin for the Treatment of a First Episode of Clostridium Difficile Infection: A Meta-analysis and Systematic Review. Cureus. 2018 Jun 11;10(6):e2778
  68. Furuya EY, Cohen B, Jia H, Larson EL. Long-Term Impact of Universal Contact Precautions on Rates of Multidrug-Resistant Organisms in ICUs: A Comparative Effectiveness Study. Infect Control Hosp Epidemiol. 2018 May;39(5):534-540
  69. Danna DM. Hospital Costs Associated with Sepsis Compared with Other Medical Conditions. Crit Care Nurs Clin North Am. 2018 Sep;30(3):389-398.
  70. Alaa Hamza Jaber Al-jelehawy, Saif Jabber Yasir, Ahmed Kifah Abed Al-waeli, Ali Radih Abulameer Sher Ali., A ssessments of HBV in patients with chronic kidney illness., International Journal of Pharmaceutical Research | Jan - Mar 2021 | Vol 13 | Issue 1, 537-540.
Download PDF
Back